The Cytochrome P450 11B2 Mitochondrial pipeline drugs market research report outlays comprehensive information on the Cytochrome P450 11B2 Mitochondrial targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses the drugs in the Cytochrome P450 11B2 Mitochondrial pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline. Buy the report here.
The report also covers products from therapy areas such as Cardiovascular, Genito Urinary System, Hormonal Disorders, and Metabolic Disorders which include the indications Resistant Hypertension, Hypertension, Chronic Kidney Disease (Chronic Renal Failure), Primary Hyperaldosteronism, Pituitary ACTH Hypersecretion (Cushing Disease), and Cardiometabolic Disease. It also reviews key players involved in Cytochrome P450 11B2 Mitochondrial targeted therapeutics development with respective active and dormant or discontinued products.
The Cytochrome P450 11B2 Mitochondrial pipeline targets constitutes close to 11 molecules. Out of which, approximately ten molecules are developed by companies and the remaining by the universities/institutes. The molecules developed by companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical, and Discovery stages are 1, 3, 2, 1, 2, and 1 respectively. Similarly, the universities portfolio in Discovery comprises 1 molecule.
Cytochrome P450 11B2 Mitochondrial overview
Aldosterone synthase is a steroid hydroxylase cytochrome P450 enzyme involved in the biosynthesis of the mineralocorticoid aldosterone. It is only expressed in the zona glomerulosa of the adrenal cortex and is primarily regulated by the renin-angiotensin system. It synthesizes aldosterone in humans and plays an important role in electrolyte balance and blood pressure. Inhibition of aldosterone synthase is used as a medical treatment for hypertension, heart failure, and renal disorders.
For a complete picture of Cytochrome P450 11B2 Mitochondrial’s drug pipeline, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.